J Hugosson
Overview
Explore the profile of J Hugosson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
632
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stinesen Kollberg K, Holmberg E, Josefsson A, Hugosson J, Arnsrud Godtman R
J Urol
. 2022 Jun;
208(5):1018-1027.
PMID: 35771961
Purpose: Even when a screening study has demonstrated a mortality reduction, the degree of pre-testing and contamination is of importance as it can dilute the "true" effect of screening. Our...
2.
Nilsson H, Stranne J, Hugosson J, Wessman C, Steineck G, Bjartell A, et al.
Hernia
. 2022 Mar;
26(2):683.
PMID: 35275321
No abstract available.
3.
Braide K, Kindblom J, Lindencrona U, Hugosson J, Pettersson N
Clin Transl Oncol
. 2020 Jul;
23(2):397-404.
PMID: 32621207
Purpose: To quantify the relationship between the rectal dose distribution and the prevalence of self-reported rectal bleeding among men treated with salvage radiotherapy (ST) delivered by three-dimensional conformal radiotherapy (3DCRT)...
4.
Nilsson H, Stranne J, Hugosson J, Wessman C, Steineck G, Bjartell A, et al.
Hernia
. 2020 Apr;
26(1):157-164.
PMID: 32279170
Purpose: In addition to incisional hernia, inguinal hernia is a recognized complication to radical retropubic prostatectomy. To compare the risk of developing inguinal and incisional hernias after open radical prostatectomy...
5.
Villers A, Bessaoud F, Tretarre B, Grosclaude P, Malavaud B, Rebillard X, et al.
Prog Urol
. 2020 Mar;
30(5):252-260.
PMID: 32197936
Introduction: European Randomized Study of Screening for Prostate Cancer (ERSPC) mortality results were reported for 7 European countries (excluding France) and showed a significant reduction in Prostate cancer (PCa) mortality....
6.
Stranne J, Axen E, Franck-Lissbrant I, Fransson P, Franlund M, Hugosson J, et al.
World J Urol
. 2019 Aug;
38(6):1397-1411.
PMID: 31388817
Purpose: The demand for objective and outcome-based facts about surgical results after radical prostatectomy (RP) is increasing. Systematic feedback is also essential for each surgeon to improve his/her performance. Methods:...
7.
FitzGerald L, Zhao S, Leonardson A, Geybels M, Kolb S, Lin D, et al.
Prostate Cancer Prostatic Dis
. 2018 Jan;
21(2):228-237.
PMID: 29298992
Background: Prostate cancer (PCa) is a leading cause of mortality and genetic factors can influence tumour aggressiveness. Several germline variants have been associated with PCa-specific mortality (PCSM), but further replication...
8.
Heijnsdijk E, de Carvalho T, Auvinen A, Zappa M, Nelen V, Kwiatkowski M, et al.
J Natl Cancer Inst
. 2014 Dec;
107(1):366.
PMID: 25505238
Background: The results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) trial showed a statistically significant 29% prostate cancer mortality reduction for the men screened in the...
9.
Horwich A, Hugosson J, de Reijke T, Wiegel T, Fizazi K, Kataja V
Ann Oncol
. 2013 Jan;
24(5):1141-62.
PMID: 23303340
The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in...
10.
Wever E, Hugosson J, Heijnsdijk E, Bangma C, Draisma G, de Koning H
Br J Cancer
. 2012 Jul;
107(5):778-84.
PMID: 22805324
Background: Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but may advance diagnosis and treatment in time and lead to overdetection and overtreatment. We estimated benefits and adverse...